mHealth for ART Adherence by HIV+ African Americans

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

109 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2020-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this grant is to create and test a mobile app to support ART adherence among HIV+ African American adults.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

NCT04855773

HIV Infections Sexually Transmitted Diseases

RECRUITING NA

Mhealth for PrEP Adherence by Young Adult MSM, Phase 2

NCT04633200

Hiv

COMPLETED NA

Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM

NCT04233931

Hiv

COMPLETED NA

Optimizing mHealth for Adherence Monitoring and Intervention

NCT03825952

HIV/AIDS

COMPLETED NA

Improving Outcomes in HIV Patients Using Mobile Phone Based Interactive Software Support

NCT02953080

Human Immunodeficiency Virus

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Phase II project will enhance the existing (Phase 1) mobile intervention by offering: 1) a two-way communication capability through which participants can: i) indicate "pill taken" in response to pill reminders, and ii) receive a positive visual icon as behavioral-economics based reinforcement for "pill taken" responses; 2) pharmacist counseling and medication support; and, 3) the addition of educational and motivational text messages. Overall aims are to: 1) expand mhealth intervention to incorporate new Phase II features; 2) evaluate effectiveness in an RCT of HIV+ African Americans; and 3) prepare marketing and commercialization plans. Our long-term goal is to increase ART medication adherence, thus decreasing health disparities, among HIV+, African-Americans.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV-1-infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial in which participants were randomly assigned to intervention group or control group.

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Investigators and participants were aware of which group participants were randomly assigned to.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mobile app

In this arm, participants received a mobile app to support ART medication adherence.

Group Type EXPERIMENTAL

On the Dot Mobile app

Intervention Type BEHAVIORAL

On the Dot is a mobile app to support HIV medication adherence. The mobile app is linked to a clinician portal through which participants can receive adherence support.

Control

In this arm, participants received care as usual.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

On the Dot Mobile app

On the Dot is a mobile app to support HIV medication adherence. The mobile app is linked to a clinician portal through which participants can receive adherence support.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

(a) self-identify as African American, (b) age 30 or older, (c) HIV positive (d) currently on ART (e) report having problems with, and interest in improving their ART adherence (f) own a smartphone (g) report English as their primary language

\-

Exclusion Criteria

(a) not self-identified as African American, (b) under age 30 (c) HIV negative (d) not currently on ART (e) do not report having problems with, or interest in, improving their ART adherence (f) do not own a smartphone (g) do not report English as a primary language and (h) participating in another research study or clinical trial (i) receiving care at non-participating site and, (j) dementia diagnosis.

\-

Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No